Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sichuan Kelun Pharmaceutical Co Ltd.

https://en.kelun.com/

Latest From Sichuan Kelun Pharmaceutical Co Ltd.

Anti-TROP2 ADCs Lung Cancer Futures Likely Lie In Earlier-Stage Disease

The discussant at ASCO’s NSCLC session said the field would need to “manage expectations” as the drugs do not appear to beat chemotherapy in all-comers. 

ASCO Clinical Trials

Bladder Cancer Failure Is Another Setback For Gilead’s Trodelvy

A missed survival endpoint in the TROPiCS-04 confirmatory trial could spell end to Trodelvy's bladder cancer use, but Gilead is more hopeful of lung cancer success.

Oncology Clinical Trials

Diversification Gains Momentum As Companies Look To Derisk China

Quietly but unambiguously, pharma firms are accelerating their diversification away from China and are now looking to other emerging markets for growth, a strategy that reflects increasing pressures from China's volume-based procurement scheme but also US-China tensions and other geopolitical risks.

China Commercial

China Biotech Interview: BeiGene Co-Founder Wang Eyes Next Big Things

BeiGene co-founder and chair of the major global biotech's Scientific Advisory Board, Dr. Xiaodong Wang, sits down with Scrip in an exclusive audio interview to shed light on the rapid rise of China's biotech innovation, the country's role in BeiGene's global strategy and the next big things to watch.

China Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Guangxi Kelun Pharmaceutical Co Ltd
    • Hunan Kelun Pharmaceutical Co Ltd
    • Hubei Kelun Pharmaceutical Co Ltd
    • Kelun Pharmaceutical Group
    • KLUS Pharma Inc
    • Shandong Kelun Pharmaceutical Co Ltd
    • Sichuan Kelun Pharmaceutical Research Co Ltd
    • Suzhou Kelun Pharmaceutical Research Co Ltd
    • Sichuan Xindi Pharmaceutical Chemicals Co Ltd
UsernamePublicRestriction

Register